Tag: Cancer
-
Studying the Impact of Stem Cell Transplants
People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.
-
New Gene Implicated in Cancer, Cellular Stress Response
Northwestern Medicine scientists have identified a gene that plays a role in cellular responses to molecular stressors, such as DNA damage and nutrient scarcity.
-
Tackling Skin Inflammation with Vitamin D
Oral vitamin D supplements reduced skin inflammation and increased immunoprotection in patients with chemical skin injuries, according to findings from a recent Northwestern Medicine clinical trial.
-
Potential Therapeutic Target for Blood Cancers Discovered
Investigators have discovered that a specific complex drives cell proliferation in mutated myeloproliferative neoplasms, suggesting this complex could serve as an ideal therapeutic target, according to a recent Northwestern medicine study.
-
Transforming the Way Cancer Vaccines are Designed and Made
A new way to significantly increase the potency of almost any vaccine has been developed by Northwestern scientists.
-
Calcium Channels Regulate Neuroinflammation and Neuropathic Pain
Northwestern Medicine investigators have discovered that specific calcium channels help regulate sex differences in the functioning of immune cells for neuroinflammation and overall neuropathic pain.
-
Understanding How Childhood Brain Tumors Develop
Scientists have identified a new cell type implicated in the development of medulloblastoma, according to a study published in Nature.
-
Novel Therapeutic Targets Discovered for Triple-Negative Breast Cancer
Targeting cellular post-transcription mechanisms in the CD73 ectoenzyme may promote anti-tumor immunity and slow cancer progression in triple-negative breast cancer, according to a recent Northwestern Medicine study.
-
Vitamin D Improves Symptoms of Toxic Erythema of Chemotherapy
High doses of vitamin D alleviated symptoms for patients with toxic erythema of chemotherapy significantly faster than current treatments, according to a recent study.
-
Improving Treatment for Hairy Cell Leukemia
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
